Rockwell Medical, Inc.RMTINASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank0
3Y CAGR-93.2%
5Y CAGR-83.0%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-93.2%/yr
vs -17.5%/yr prior
5Y CAGR
-83.0%/yr
Recent deceleration
Acceleration
-75.6pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
5 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$1000.00-94.7%
2024$19000.00-98.3%
2023$1.11M-64.5%
2022$3.12M-54.4%
2021$6.83M-3.6%
2020$7.09M+3.0%
2019$6.89M+2.1%
2018$6.74M+6.7%
2017$6.32M+8.2%
2016$5.84M-